Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI
Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To determine the acute and chronic effects of a short course of treatment on spinal cord
injured (SCI) individuals with either an anticholinergic agent (tiotropium) or with a β₂
agonist (Salmeterol) on:
- Fraction of expired NO (FeNO)
- Selected Biomarkers of inflammation in exhaled breath condensates (EBC)
- Pulmonary function, as measured by pulmonary function tests and body plethysmography